Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Koya

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Diabetes, Obesity & Metabolism|July 2, 2010
Acupuncture: is it effective for treatment of insulin resistance?F Liang, D Koya
Cutis|June 1, 1978
Cutaneous manifestations of gastrointestinal diseaseE D Loeffel, D Koya
Diabetes|May 30, 1998
Protein kinase C activation and the development of diabetic complicationsD Koya, G L King
Contributions to Nephrology|October 23, 2001
Mesangial cell dysfunction as a pathogenesis of diabetic nephropathyM Haneda, D Koya, R Kikkawa
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 29, 2001
Cellular mechanisms in the development and progression of diabetic nephropathy: activation of the DAG-PKC-ERK pathwayM Haneda, D Koya, R Kikkawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 10, 1997
[Diabetic nephropathy--definition, stages, measurement of albuminuria, and therapy]D Koya, M Haneda, R Kikkawa
Journal of Molecular Medicine (Berlin, Germany)|February 14, 1998
Protein kinase C activation and its role in the development of vascular complications in diabetes mellitusH Ishii, D Koya, G L King
Kidney International. Supplement|September 1, 1997
Diabetic vascular dysfunctions: a model of excessive activation of protein kinase CG L King, H Ishii, D Koya
The Journal of Diabetic Complications|April 1, 1991
Mesangial cell dysfunctionR Kikkawa, M Haneda, D Koya, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 9, 2000
[Kidney disease and insulin resistance--clinical impact of thiazolidinedione compounds for kidney disease]K Isshiki, M Haneda, D Koya, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Diabetes, Obesity & Metabolism|July 2, 2010
Acupuncture: is it effective for treatment of insulin resistance?F Liang, D Koya
Cutis|June 1, 1978
Cutaneous manifestations of gastrointestinal diseaseE D Loeffel, D Koya
Diabetes|May 30, 1998
Protein kinase C activation and the development of diabetic complicationsD Koya, G L King
Contributions to Nephrology|October 23, 2001
Mesangial cell dysfunction as a pathogenesis of diabetic nephropathyM Haneda, D Koya, R Kikkawa
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 29, 2001
Cellular mechanisms in the development and progression of diabetic nephropathy: activation of the DAG-PKC-ERK pathwayM Haneda, D Koya, R Kikkawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 10, 1997
[Diabetic nephropathy--definition, stages, measurement of albuminuria, and therapy]D Koya, M Haneda, R Kikkawa
Journal of Molecular Medicine (Berlin, Germany)|February 14, 1998
Protein kinase C activation and its role in the development of vascular complications in diabetes mellitusH Ishii, D Koya, G L King
Kidney International. Supplement|September 1, 1997
Diabetic vascular dysfunctions: a model of excessive activation of protein kinase CG L King, H Ishii, D Koya
The Journal of Diabetic Complications|April 1, 1991
Mesangial cell dysfunctionR Kikkawa, M Haneda, D Koya, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 9, 2000
[Kidney disease and insulin resistance--clinical impact of thiazolidinedione compounds for kidney disease]K Isshiki, M Haneda, D Koya, et al.
Pageof 6